Janine Lupo, PhD

Title(s)Professor, Radiology
SchoolSchool of Medicine
Address1700 4th Street, #303D
San Francisco CA 94158
Phone415-502-0646
PronounsShe/Her/Hers
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of PennslyvaniaBSE2001School of Engineering and Applied Sciences
    University of California, Berkeley & San FranciscoPhD2006Joint Graduate Program in Bioegineering
    University of California, San Francisco, CA2021Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    Mark Foundation for Cancer Research2021Emerging Leader Award Finalist
    UCSF2017Johnson & Johnson Women In STEM2D award in Engineering, UCSF nominee
    UCSF2016RAP Family Support Award
    National Institutes of Health 2012Clinical Loan Repayment Program Continuation Award
    UCSF2012RAP Grants Novel Clinical/Translational Methods Award
    UCSF2011Radiology Symposium Poster Award
    UCSF BTS Symposium2010Honorable Mention Poster Award
    National Institutes of Health 2010Clinical Loan Repayment Program Award
    UCSF2010Brain Tumor SPORE Career Development Award
    ISMRM Conference 2010Neuroimaging Poster Award Nomination
    UCSF2008Radiology Symposium Poster Award
    UCSF Department of Radiology and Biomedical Imaging2006Surbeck Scholar Award

    Collapse Overview 
    Collapse Overview
    Janine Lupo, PhD, is a Professor in the Surbeck Laboratory of Advanced Imaging and Neuroimaging Research Interest Group of the Department of Radiology and Biomedical Imaging. She is a member of the UCSF/UC Berkeley Graduate Group in Bioengineering, Helen Diller Family Comprehensive Cancer Center, Institute for Computational Health Sciences, and Quantitative Biosciences Institute. Dr. Lupo received her BSE in Bioengineering at the University of Pennsylvania, School of Engineering and Applied Science in Philadelphia before completing her PhD at the UCSF/UCB PhD Joint Graduate Group in Bioengineering. Before accepting an in residence position, Dr. Lupo was an Assistant and Associate Researcher in the Department of Radiology and Biomedical Imaging at UCSF.

    Dr. Lupo’s research focuses on the development and application of novel MR imaging data acquisition, processing, and analysis techniques for the evaluation of patients with brain tumors and other neurological diseases using our research 3T and 7T whole body scanners. This includes the development of quantitative algorithms critical for processing data from advanced acquisitions for patient studies, implementation of statistical and machine learning models to relate imaging markers with biological characteristics from pathology and clinical outcome in order to both identify patients who would benefit most for a given therapy, and monitor the effects of therapy over time on tumor control, normal brain tissue structure, and cognition.

    Dr. Lupo has been the Principal or Co-Principal Investigator for multiple NIH and DoD grants, as well as a co-Project leader of 2 projects within an NIH Programmatic Project Grant and Brain Tumor SPORE Grant. She has published over 75 research articles.

    Expertise:
    Bioengineering

    Specialty:
    Neuroimaging

    Professional Interests:
    Magnetic resonance imaging, ultra-high field MRI, algorithm development for quantitative image analysis, imaging biomarker discovery, brain cancer, neurological diseases, evaluation of therapy, the effects of therapy on cognition, statistical modeling, and deep learning

    Collapse Research 
    Collapse Research Activities and Funding
    3D Multi-Contrast MRI with Automatic Brain Tissue and Lesion Segmentation
    NIH R21CA238137Dec 1, 2019 - Nov 30, 2021
    Role: Co-PI
    Mitigation of preanalytic factors influencing brain tumor protein phosphorylation
    NIH U01CA229345Apr 1, 2019 - Mar 31, 2024
    Role: Co-Investigator
    IMPROVED MONITORING OF PREMANIFEST AND EARLY HUNTINGTONS USING 7T MULTIMODAL MRI
    NIH R01NS099564Jul 1, 2017 - Jun 30, 2022
    Role: Co-PI
    MICROBLEEDS AS A MARKER OF RADIATION-INDUCED BRAIN INJURY IN PEDIATRIC PATIENTS
    NIH R01HD079568Apr 1, 2015 - Jan 31, 2021
    Role: PI
    Brain Vascular Malformation Consortium: Predictor's of Clinical Course
    NIH U54NS065705Sep 30, 2009 - Jun 30, 2024
    Role: Co-Investigator
    Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma
    NIH P01CA118816Dec 1, 2005 - Jul 31, 2024
    Role: Director of Imaging Core
    Brain Tumor SPORE Grant
    NIH 2P50CA097257-16Sep 20, 2002 - Aug 31, 2023
    Role: Co-PI of Project 2

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Improving the Generalizability of Deep Learning for T2-Lesion Segmentation of Gliomas in the Post-Treatment Setting. Bioengineering (Basel). 2024 May 16; 11(5). Ellison J, Caliva F, Damasceno P, Luks TL, LaFontaine M, Cluceru J, Kemisetti A, Li Y, Molinaro AM, Pedoia V, Villanueva-Meyer JE, Lupo JM. PMID: 38790363; PMCID: PMC11117752.
      View in: PubMed   Mentions:
    2. Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary Study. Cancers (Basel). 2024 Apr 17; 16(8). Liu J, Jakary A, Villanueva-Meyer JE, Butowski NA, Saloner D, Clarke JL, Taylor JW, Oberheim Bush NA, Chang SM, Xu D, Lupo JM. PMID: 38672606; PMCID: PMC11049314.
      View in: PubMed   Mentions:
    3. Quantitative Assessment of Preanalytic Variables on Clinical Evaluation of PI3/AKT/mTOR Signaling Activity in Diffuse Glioma. Mod Pathol. 2024 Jun; 37(6):100488. Beccari S, Mohamed E, Voong V, Hilz S, Lafontaine M, Shai A, Lim Y, Martinez J, Switzman B, Yu RL, Lupo JM, Chang EF, Hervey-Jumper SL, Berger MS, Costello JF, Phillips JJ. PMID: 38588881.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    4. Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast Enhancement. Neurosurgery. 2024 Mar 19. Bobholz SA, Lowman AK, Connelly JM, Duenweg SR, Winiarz A, Nath B, Kyereme F, Brehler M, Bukowy J, Coss D, Lupo JM, Phillips JJ, Ellingson BM, Krucoff MO, Mueller WM, Banerjee A, LaViolette PS. PMID: 38501824.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell. 2024 01 18; 187(2):446-463.e16. Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C, Grishanina NR, Kwok D, Stevers NO, Jin Q, Youngblood MW, Stasiak LA, Hou Y, Wang J, Yamaguchi TN, Lafontaine M, Shai A, Smirnov IV, Solomon DA, Chang SM, Hervey-Jumper SL, Berger MS, Lupo JM, Okada H, Phillips JJ, Boutros PC, Gallo M, Oldham MC, Yue F, Costello JF. PMID: 38242087; PMCID: PMC10832360.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    6. Advanced Hyperpolarized 13C Metabolic Imaging Protocol for Patients with Gliomas: A Comprehensive Multimodal MRI Approach. Cancers (Basel). 2024 Jan 13; 16(2). Autry AW, Vaziri S, Gordon JW, Chen HY, Kim Y, Dang D, LaFontaine M, Noeske R, Bok R, Villanueva-Meyer JE, Clarke JL, Oberheim Bush NA, Chang SM, Xu D, Lupo JM, Larson PEZ, Vigneron DB, Li Y. PMID: 38254844; PMCID: PMC10814348.
      View in: PubMed   Mentions:
    7. Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRI. J Magn Reson Imaging. 2024 Jan 11. Yao J, Morrison MA, Jakary A, Avadiappan S, Rowley P, Glueck J, Driscoll T, Geschwind MD, Nelson AB, Possin KL, Xu D, Hess CP, Lupo JM. PMID: 38206986.
      View in: PubMed   Mentions:    Fields:    
    8. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling. Stroke. 2024 01; 55(1):31-39. Hage S, Kinkade S, Girard R, Flemming KD, Kim H, Torbey MT, Huang J, Huston J, Shu Y, Selwyn RG, Hart BL, Mabray MC, Feghali J, Sair HI, Narvid J, Lupo JM, Lee J, Stadnik A, Alcazar-Felix RJ, Shenkar R, Hobson N, DeBiasse D, Lane K, McBee NA, Treine K, Ostapkovich N, Wang Y, Thompson RE, Koenig JI, Carroll T, Hanley DF, Awad IA. PMID: 38134265; PMCID: PMC10752356.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome. Stroke. 2024 01; 55(1):22-30. Flemming KD, Kim H, Hage S, Mandrekar J, Kinkade S, Girard R, Torbey M, Huang J, Huston J, Shu Y, Lanzino G, Selwyn R, Hart B, Mabray M, Feghali J, Sair HI, Narvid J, Lupo JM, Lee J, Stadnik A, Alcazar-Felix RJ, Shenkar R, Lane K, McBee N, Treine K, Ostapkovich N, Wang Y, Thompson R, Koenig JI, Carroll T, Hanley D, Awad I. PMID: 38134268; PMCID: PMC10752254.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    10. Ethical considerations of preclinical models in imaging research. Magn Reson Med. 2024 Mar; 91(3):858-859. Garza-Villarreal EA, Moy L, Mao H, Hussain T, Lupo JM, Fleischer CC, Scott AD. PMID: 37984415.
      View in: PubMed   Mentions:    Fields:    
    11. Evaluation of deep learning models for quality control of MR spectra. Front Neurosci. 2023; 17:1219343. Vaziri S, Liu H, Xie E, Ratiney H, Sdika M, Lupo JM, Xu D, Li Y. PMID: 37706154; PMCID: PMC10495580.
      View in: PubMed   Mentions:
    12. Ethical Considerations for MRI Research in Human Subjects in the Era of Precision Medicine. J Magn Reson Imaging. 2024 May; 59(5):1864-1866. Mao H, Garza-Villarreal EA, Moy L, Hussain T, Scott AD, Lupo JM, Zhou XJ, Fleischer CC. PMID: 37606080.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Multi-parametric hyperpolarized 13C/1H imaging reveals Warburg-related metabolic dysfunction and associated regional heterogeneity in high-grade human gliomas. Neuroimage Clin. 2023; 39:103501. Autry AW, Vaziri S, LaFontaine M, Gordon JW, Chen HY, Kim Y, Villanueva-Meyer JE, Molinaro A, Clarke JL, Oberheim Bush NA, Xu D, Lupo JM, Larson PEZ, Vigneron DB, Chang SM, Li Y. PMID: 37611371; PMCID: PMC10470324.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling. medRxiv. 2023 Jun 05. Hage S, Kinkade S, Girard R, Flemming KD, Kim H, Torbey MT, Huang J, Huston J, Shu Y, Selwyn RG, Hart BL, Mabray MC, Feghali J, Sair HI, Narvid J, Lupo JM, Lee J, Stadnik A, Alcazar R, Shenkar R, Hobson N, DeBiasse D, Lane K, McBee N, Treine K, Ostapkovich N, Wang Y, Thompson RE, Mendoza-Puccini C, Koenig J, Carroll T, Hanley DF, Awad IA. PMID: 37333396; PMCID: PMC10275015.
      View in: PubMed   Mentions:
    15. Editorial for "Relationship Between Microstructural Alterations and Cognitive Decline After Whole-Brain Radiation Therapy for Brain Metastases: An Exploratory Whole-Brain MR Analysis Based on Neurite Orientation Dispersion and Density Imaging". J Magn Reson Imaging. 2024 01; 59(1):253-254. Yao J, Morrison MA, Lupo JM. PMID: 37194681.
      View in: PubMed   Mentions:    Fields:    
    16. Evaluation of major depressive disorder using 7 Tesla phase sensitive neuroimaging before and after mindfulness-based cognitive therapy. J Affect Disord. 2023 08 15; 335:383-391. Jakary A, Lupo JM, Mackin S, Yin A, Murray D, Yang T, Mukherjee P, Larson P, Xu D, Eisendrath S, Luks T, Li Y. PMID: 37192691.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. A feasibility study for quantitative assessment of cerebrovascular malformations using flutriciclamide ([18F]GE-180) PET/MRI. Front Med (Lausanne). 2023; 10:1091463. Kim SJW, Lupo JM, Chen Y, Pampaloni MH, VanBrocklin HF, Narvid J, Kim H, Seo Y. PMID: 37089589; PMCID: PMC10116613.
      View in: PubMed   Mentions: 1  
    18. DeepSWI: Using Deep Learning to Enhance Susceptibility Contrast on T2*-Weighted MRI. J Magn Reson Imaging. 2023 10; 58(4):1200-1210. Genc O, Morrison MA, Villanueva-Meyer JE, Burns B, Hess CP, Banerjee S, Lupo JM. PMID: 36733222; PMCID: PMC10443940.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease. Neuroimage. 2023 01; 265:119788. Yao J, Morrison MA, Jakary A, Avadiappan S, Chen Y, Luitjens J, Glueck J, Driscoll T, Geschwind MD, Nelson AB, Villanueva-Meyer JE, Hess CP, Lupo JM. PMID: 36476567.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phase. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac175. Avalos LN, Luks TL, Gleason T, Damasceno P, Li Y, Lupo JM, Phillips J, Oberheim Bush NA, Taylor JW, Chang SM, Villanueva-Meyer JE. PMID: 36479058; PMCID: PMC9721386.
      View in: PubMed   Mentions: 1  
    21. Functional network alterations in young brain tumor patients with radiotherapy-induced memory impairments and vascular injury. Front Neurol. 2022; 13:921984. Morrison MA, Walter S, Mueller S, Felton E, Jakary A, Stoller S, Molinaro AM, Braunstein SE, Hess CP, Lupo JM. PMID: 36172034; PMCID: PMC9511024.
      View in: PubMed   Mentions:
    22. Assessment of higher-order singular value decomposition denoising methods on dynamic hyperpolarized [1-13C]pyruvate MRI data from patients with glioma. Neuroimage Clin. 2022; 36:103155. Vaziri S, Autry AW, Lafontaine M, Kim Y, Gordon JW, Chen HY, Hu JY, Lupo JM, Chang SM, Clarke JL, Villanueva-Meyer JE, Bush NAO, Xu D, Larson PEZ, Vigneron DB, Li Y. PMID: 36007439; PMCID: PMC9421383.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Improving the Automatic Classification of Brain MRI Acquisition Contrast with Machine Learning. J Digit Imaging. 2023 02; 36(1):289-305. Cluceru J, Lupo JM, Interian Y, Bove R, Crane JC. PMID: 35941406; PMCID: PMC9984597.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. An Integrated Analysis of Clinical, Genomic, and Imaging Features Reveals Predictors of Neurocognitive Outcomes in a Longitudinal Cohort of Pediatric Cancer Survivors, Enriched with CNS Tumors (Rad ART Pro). Front Oncol. 2022; 12:874317. Kline C, Stoller S, Byer L, Samuel D, Lupo JM, Morrison MA, Rauschecker AM, Nedelec P, Faig W, Dubal DB, Fullerton HJ, Mueller S. PMID: 35814456; PMCID: PMC9259981.
      View in: PubMed   Mentions: 2  
    25. Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging. Neuro Oncol. 2022 04 01; 24(4):639-652. Cluceru J, Interian Y, Phillips JJ, Molinaro AM, Luks TL, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Shai A, Chunduru P, Pedoia V, Villanueva-Meyer JE, Chang SM, Lupo JM. PMID: 34653254; PMCID: PMC8972294.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    26. Comparison of quantitative susceptibility mapping methods on evaluating radiation-induced cerebral microbleeds and basal ganglia at 3T and 7T. NMR Biomed. 2022 05; 35(5):e4666. Chen Y, Genc O, Poynton CB, Banerjee S, Hess CP, Lupo JM. PMID: 35075701; PMCID: PMC10443943.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Stroke. 2021 12; 52(12):3829-3838. Kim H, Flemming KD, Nelson JA, Lui A, Majersik JJ, Cruz MD, Zabramski J, Trevizo O, Lanzino G, Zafar A, Torbey M, Mabray MC, Robinson M, Narvid J, Lupo J, Thompson RE, Hanley DF, McBee N, Treine K, Ostapkovich N, Stadnik A, Piedad K, Hobson N, Carroll T, Shkoukani A, Carrión-Penagos J, Mendoza-Puccini C, Koenig JI, Awad I. PMID: 34525838; PMCID: PMC8608704.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Relationship between 7T MR-angiography features of vascular injury and cognitive decline in young brain tumor patients treated with radiation therapy. J Neurooncol. 2021 May; 153(1):143-152. Avadiappan S, Morrison MA, Jakary A, Felton E, Stoller S, Hess CP, Molinaro AM, Braunstein SE, Mueller S, Lupo JM. PMID: 33893923; PMCID: PMC8172069.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. 7-T Magnetic Resonance Imaging in the Management of Brain Tumors. Magn Reson Imaging Clin N Am. 2021 Feb; 29(1):83-102. Morrison MA, Lupo JM. PMID: 33237018.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    30. Pilot Study of Hyperpolarized 13C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers. AJNR Am J Neuroradiol. 2021 01; 42(1):178-184. Autry AW, Park I, Kline C, Chen HY, Gordon JW, Raber S, Hoffman C, Kim Y, Okamoto K, Vigneron DB, Lupo JM, Prados M, Li Y, Xu D, Mueller S. PMID: 33272950; PMCID: PMC7814790.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    31. Diffusion MRI as an early marker of response to immune checkpoint inhibitors. Neuro Oncol. 2020 11 26; 22(11):1557-1558. Lupo JM. PMID: 33045738; PMCID: PMC7690350.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    32. Longitudinal outcomes of cochlear implantation and bimodal hearing in a large group of adults: A multicenter clinical study. Am J Otolaryngol. 2021 Jan - Feb; 42(1):102773. Kelsall D, Lupo J, Biever A. PMID: 33161258.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    33. Centrally Reduced Diffusion Sign for Differentiation between Treatment-Related Lesions and Glioma Progression: A Validation Study. AJNR Am J Neuroradiol. 2020 11; 41(11):2049-2054. Alcaide-Leon P, Cluceru J, Lupo JM, Yu TJ, Luks TL, Tihan T, Bush NA, Villanueva-Meyer JE. PMID: 33060101; PMCID: PMC7658838.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    34. Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomas. Neuro Oncol. 2020 10 14; 22(10):1516-1526. Cluceru J, Nelson SJ, Wen Q, Phillips JJ, Shai A, Molinaro AM, Alcaide-Leon P, Olson MP, Nair D, LaFontaine M, Chunduru P, Villanueva-Meyer JE, Cha S, Chang SM, Berger MS, Lupo JM. PMID: 32319527; PMCID: PMC7566399.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Rate of radiation-induced microbleed formation on 7T MRI relates to cognitive impairment in young patients treated with radiation therapy for a brain tumor. Radiother Oncol. 2021 01; 154:145-153. Morrison MA, Mueller S, Felton E, Jakary A, Stoller S, Avadiappan S, Yuan J, Molinaro AM, Braunstein S, Banerjee A, Hess CP, Lupo JM. PMID: 32966846; PMCID: PMC8208731.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    36. Simultaneous multi-slice spin- and gradient-echo dynamic susceptibility-contrast perfusion-weighted MRI of gliomas. NMR Biomed. 2021 01; 34(1):e4399. Han M, Yang B, Fernandez B, Lafontaine M, Alcaide-Leon P, Jakary A, Burns BL, Morrison MA, Villanueva-Meyer JE, Chang SM, Banerjee S, Lupo JM. PMID: 32844496.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    37. Characterization of serial hyperpolarized 13C metabolic imaging in patients with glioma. Neuroimage Clin. 2020; 27:102323. Autry AW, Gordon JW, Chen HY, LaFontaine M, Bok R, Van Criekinge M, Slater JB, Carvajal L, Villanueva-Meyer JE, Chang SM, Clarke JL, Lupo JM, Xu D, Larson PEZ, Vigneron DB, Li Y. PMID: 32623139; PMCID: PMC7334458.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    38. A Fully Automated Method for Segmenting Arteries and Quantifying Vessel Radii on Magnetic Resonance Angiography Images of Varying Projection Thickness. Front Neurosci. 2020; 14:537. Avadiappan S, Payabvash S, Morrison MA, Jakary A, Hess CP, Lupo JM. PMID: 32612496; PMCID: PMC7308498.
      View in: PubMed   Mentions: 7  
    39. QSMGAN: Improved Quantitative Susceptibility Mapping using 3D Generative Adversarial Networks with increased receptive field. Neuroimage. 2020 02 15; 207:116389. Chen Y, Jakary A, Avadiappan S, Hess CP, Lupo JM. PMID: 31760151; PMCID: PMC8081272.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    40. Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and heat-shock protein vaccine therapy. J Neurooncol. 2020 Jan; 146(1):71-78. Alcaide-Leon P, Luks TL, Lafontaine M, Lupo JM, Okada H, Clarke JL, Villanueva-Meyer JE. PMID: 31728884; PMCID: PMC6939141.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    41. Toward Automatic Detection of Radiation-Induced Cerebral Microbleeds Using a 3D Deep Residual Network. J Digit Imaging. 2019 10; 32(5):766-772. Chen Y, Villanueva-Meyer JE, Morrison MA, Lupo JM. PMID: 30511280; PMCID: PMC6737152.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    42. Technical Note: Simultaneous segmentation and relaxometry for MRI through multitask learning. Med Phys. 2019 Oct; 46(10):4610-4621. Cao P, Liu J, Tang S, Leynes AP, Lupo JM, Xu D, Larson PEZ. PMID: 31396973; PMCID: PMC6800607.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Correlation of Tumor Perfusion Between Carbon-13 Imaging with Hyperpolarized Pyruvate and Dynamic Susceptibility Contrast MRI in Pre-Clinical Model of Glioblastoma. Mol Imaging Biol. 2019 08; 21(4):626-632. Park I, Lupo JM, Nelson SJ. PMID: 30225760; PMCID: PMC8172073.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    44. Risk factors of radiotherapy-induced cerebral microbleeds and serial analysis of their size compared with white matter changes: A 7T MRI study in 113 adult patients with brain tumors. J Magn Reson Imaging. 2019 09; 50(3):868-877. Morrison MA, Hess CP, Clarke JL, Butowski N, Chang SM, Molinaro AM, Lupo JM. PMID: 30663150; PMCID: PMC6642688.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    45. Machine Learning in Neurooncology Imaging: From Study Request to Diagnosis and Treatment. AJR Am J Roentgenol. 2019 01; 212(1):52-56. Villanueva-Meyer JE, Chang P, Lupo JM, Hess CP, Flanders AE, Kohli M. PMID: 30403523.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    46. A comparison of coil combination strategies in 3D multi-channel MRSI reconstruction for patients with brain tumors. NMR Biomed. 2018 11; 31(11):e3929. Vareth M, Lupo J, Larson P, Nelson S. PMID: 30168205; PMCID: PMC6290901.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    47. A user-guided tool for semi-automated cerebral microbleed detection and volume segmentation: Evaluating vascular injury and data labelling for machine learning. Neuroimage Clin. 2018; 20:498-505. Morrison MA, Payabvash S, Chen Y, Avadiappan S, Shah M, Zou X, Hess CP, Lupo JM. PMID: 30140608; PMCID: PMC6104340.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    48. Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. Transl Oncol. 2017 Dec; 10(6):895-903. Autry A, Phillips JJ, Maleschlijski S, Roy R, Molinaro AM, Chang SM, Cha S, Lupo JM, Nelson SJ. PMID: 28942218; PMCID: PMC5612804.
      View in: PubMed   Mentions: 8  
    49. Relationship between radiation dose and microbleed formation in patients with malignant glioma. Radiat Oncol. 2017 Aug 10; 12(1):126. Wahl M, Anwar M, Hess CP, Chang SM, Lupo JM. PMID: 28797254; PMCID: PMC5553662.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    50. Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas. Cancer. 2017 Dec 01; 123(23):4631-4639. Wahl M, Chang SM, Phillips JJ, Molinaro AM, Costello JF, Mazor T, Alexandrescu S, Lupo JM, Nelson SJ, Berger M, Prados M, Taylor JW, Butowski N, Clarke JL, Haas-Kogan D. PMID: 28759109; PMCID: PMC5693663.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    51. Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI. Radiat Res. 2017 09; 188(3):303-313. Anwar M, Molinaro AM, Morin O, Chang SM, Haas-Kogan DA, Nelson SJ, Lupo JM. PMID: 28723274; PMCID: PMC5628052.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    52. Automated algorithm for counting microbleeds in patients with familial cerebral cavernous malformations. Neuroradiology. 2017 Jul; 59(7):685-690. Zou X, Hart BL, Mabray M, Bartlett MR, Bian W, Nelson J, Morrison LA, McCulloch CE, Hess CP, Lupo JM, Kim H. PMID: 28534135; PMCID: PMC5501247.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors. Neuro Oncol. 2016 11; 18(11):1548-1558. Roddy E, Sear K, Felton E, Tamrazi B, Gauvain K, Torkildson J, Buono BD, Samuel D, Haas-Kogan DA, Chen J, Goldsby RE, Banerjee A, Lupo JM, Molinaro AM, Fullerton HJ, Mueller S. PMID: 27540084; PMCID: PMC5063522.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    54. Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab. J Neurooncol. 2016 10; 130(1):171-179. Nelson SJ, Li Y, Lupo JM, Olson M, Crane JC, Molinaro A, Roy R, Clarke J, Butowski N, Prados M, Cha S, Chang SM. PMID: 27535746; PMCID: PMC5069332.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    55. Magnetic resonance analysis of malignant transformation in recurrent glioma. Neuro Oncol. 2016 08; 18(8):1169-79. Jalbert LE, Neill E, Phillips JJ, Lupo JM, Olson MP, Molinaro AM, Berger MS, Chang SM, Nelson SJ. PMID: 26911151; PMCID: PMC4933480.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    56. Investigating tumor perfusion by hyperpolarized 13 C MRI with comparison to conventional gadolinium contrast-enhanced MRI and pathology in orthotopic human GBM xenografts. Magn Reson Med. 2017 02; 77(2):841-847. Park I, von Morze C, Lupo JM, Ardenkjaer-Larsen JH, Kadambi A, Vigneron DB, Nelson SJ. PMID: 26892398; PMCID: PMC4991955.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    57. Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials. Transl Oncol. 2015 Dec; 8(6):446-55. Wen Q, Jalilian L, Lupo JM, Li Y, Roy R, Molinaro AM, Chang SM, Prados M, Butowski N, Clarke J, Nelson SJ. PMID: 26692525; PMCID: PMC4700297.
      View in: PubMed   Mentions: 1  
    58. Magnetic Resonance (MR) Metabolic Imaging in Glioma. Brain Pathol. 2015 Nov; 25(6):769-80. Chaumeil MM, Lupo JM, Ronen SM. PMID: 26526945; PMCID: PMC8029127.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    59. Clinically feasible NODDI characterization of glioma using multiband EPI at 7 T. Neuroimage Clin. 2015; 9:291-9. Wen Q, Kelley DA, Banerjee S, Lupo JM, Chang SM, Xu D, Hess CP, Nelson SJ. PMID: 26509116; PMCID: PMC4579286.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    60. The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma. Neuro Oncol. 2016 Jan; 18(1):87-95. Lupo JM, Molinaro AM, Essock-Burns E, Butowski N, Chang SM, Cha S, Nelson SJ. PMID: 26206774; PMCID: PMC4677411.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    61. Simultaneous imaging of radiation-induced cerebral microbleeds, arteries and veins, using a multiple gradient echo sequence at 7 Tesla. J Magn Reson Imaging. 2015 Aug; 42(2):269-79. Bian W, Banerjee S, Kelly DA, Hess CP, Larson PE, Chang SM, Nelson SJ, Lupo JM. PMID: 25471321; PMCID: PMC4876721.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    62. Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. J Neurooncol. 2015 Jan; 121(2):331-9. Wen Q, Jalilian L, Lupo JM, Molinaro AM, Chang SM, Clarke J, Prados M, Nelson SJ. PMID: 25351579; PMCID: PMC4311062.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    63. Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma. Semin Radiat Oncol. 2014 Oct; 24(4):248-58. Lupo JM, Nelson SJ. PMID: 25219809; PMCID: PMC4876711.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    64. Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels. J Magn Reson Imaging. 2015 May; 41(5):1332-41. Li Y, Larson P, Chen AP, Lupo JM, Ozhinsky E, Kelley D, Chang SM, Nelson SJ. PMID: 24935758; PMCID: PMC4269580.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    65. Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma. Cancer Res. 2014 Aug 15; 74(16):4247-57. Chaumeil MM, Larson PE, Woods SM, Cai L, Eriksson P, Robinson AE, Lupo JM, Vigneron DB, Nelson SJ, Pieper RO, Phillips JJ, Ronen SM. PMID: 24876103; PMCID: PMC4134724.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    66. Quantitative 7T phase imaging in premanifest Huntington disease. AJNR Am J Neuroradiol. 2014 Sep; 35(9):1707-13. Apple AC, Possin KL, Satris G, Johnson E, Lupo JM, Jakary A, Wong K, Kelley DA, Kang GA, Sha SJ, Kramer JH, Geschwind MD, Nelson SJ, Hess CP. PMID: 24742810; PMCID: PMC4425411.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    67. Susceptibility-weighted MR imaging of radiation therapy-induced cerebral microbleeds in patients with glioma: a comparison between 3T and 7T. Neuroradiology. 2014 Feb; 56(2):91-6. Bian W, Hess CP, Chang SM, Nelson SJ, Lupo JM. PMID: 24281386; PMCID: PMC4940363.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    68. Computer-aided detection of radiation-induced cerebral microbleeds on susceptibility-weighted MR images. Neuroimage Clin. 2013; 2:282-90. Bian W, Hess CP, Chang SM, Nelson SJ, Lupo JM. PMID: 24179783; PMCID: PMC3777794.
      View in: PubMed   Mentions: 29     Fields:    
    69. Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging. Neuro Oncol. 2013 May; 15(5):607-17. Li Y, Lupo JM, Parvataneni R, Lamborn KR, Cha S, Chang SM, Nelson SJ. PMID: 23393206; PMCID: PMC3635514.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    70. Using susceptibility-weighted imaging to determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in patients with glioblastoma multiforme. Neuro Oncol. 2013 Apr; 15(4):480-9. Lupo JM, Essock-Burns E, Molinaro AM, Cha S, Chang SM, Butowski N, Nelson SJ. PMID: 23393208; PMCID: PMC3607266.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    71. Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM. J Magn Reson Imaging. 2013 Aug; 38(2):388-400. Essock-Burns E, Phillips JJ, Molinaro AM, Lupo JM, Cha S, Chang SM, Nelson SJ. PMID: 23281184; PMCID: PMC3711964.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    72. A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler. 2013 Jan; 19(1):69-75. Bian W, Harter K, Hammond-Rosenbluth KE, Lupo JM, Xu D, Kelley DA, Vigneron DB, Nelson SJ, Pelletier D. PMID: 22641301.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    73. Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status. Clin Vaccine Immunol. 2012 Jun; 19(6):929-34. Lupo J, Germi R, Semenova T, Buisson M, Seigneurin JM, Morand P. PMID: 22539474; PMCID: PMC3370434.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    74. T1 and T2 Metabolite Relaxation Times in Normal Brain at 3T and 7T. J Mol Imaging Dynam. 2012; S1:002. Li Y, Xu D, Ozturk-Isik E, Lupo JM, Chen AP, Vigneron DB, Nelson SJ. View Publication.
    75. Advances in ultra-high field MRI for the clinical management of patients with brain tumors. Curr Opin Neurol. 2011 Dec; 24(6):605-15. Lupo JM, Li Y, Hess CP, Nelson SJ. PMID: 22045220.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    76. 7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):e493-500. Lupo JM, Chuang CF, Chang SM, Barani IJ, Jimenez B, Hess CP, Nelson SJ. PMID: 22000750; PMCID: PMC3268881.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansPHPublic Health
    77. Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme. Neuro Oncol. 2011 May; 13(5):546-57. Li Y, Lupo JM, Polley MY, Crane JC, Bian W, Cha S, Chang S, Nelson SJ. PMID: 21297128; PMCID: PMC3093330.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    78. Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma. Neuro Oncol. 2011 Jan; 13(1):119-31. Essock-Burns E, Lupo JM, Cha S, Polley MY, Butowski NA, Chang SM, Nelson SJ. PMID: 21036812; PMCID: PMC3018901.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    79. Multi-channel metabolic imaging, with SENSE reconstruction, of hyperpolarized [1-(13)C] pyruvate in a live rat at 3.0 tesla on a clinical MR scanner. J Magn Reson. 2011 Jan; 208(1):171-7. Tropp J, Lupo JM, Chen A, Calderon P, McCune D, Grafendorfer T, Ozturk-Isik E, Larson PE, Hu S, Yen YF, Robb F, Bok R, Schulte R, Xu D, Hurd R, Vigneron D, Nelson S. PMID: 21130012; PMCID: PMC3387549.
      View in: PubMed   Mentions: 30     Fields:    Translation:Animals
    80. Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging. Transl Oncol. 2009 Dec; 2(4):271-80. Bian W, Khayal IS, Lupo JM, McGue C, Vandenberg S, Lamborn KR, Chang SM, Cha S, Nelson SJ. PMID: 19956389; PMCID: PMC2781083.
      View in: PubMed   Mentions: 20  
    81. Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer. Magn Reson Imaging. 2010 Feb; 28(2):153-62. Lupo JM, Chen AP, Zierhut ML, Bok RA, Cunningham CH, Kurhanewicz J, Vigneron DB, Nelson SJ. PMID: 19695815; PMCID: PMC3075841.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    82. GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7 T. Magn Reson Imaging. 2009 May; 27(4):480-8. Lupo JM, Banerjee S, Hammond KE, Kelley DA, Xu D, Chang SM, Vigneron DB, Majumdar S, Nelson SJ. PMID: 18823730; PMCID: PMC4905599.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    83. Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson. 2008 Jul; 193(1):139-46. Cunningham CH, Chen AP, Lustig M, Hargreaves BA, Lupo J, Xu D, Kurhanewicz J, Hurd RE, Pauly JM, Nelson SJ, Vigneron DB. PMID: 18424203; PMCID: PMC3051833.
      View in: PubMed   Mentions: 58     Fields:    Translation:Animals
    84. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage. 2008 Feb 15; 39(4):1682-92. Hammond KE, Lupo JM, Xu D, Metcalf M, Kelley DA, Pelletier D, Chang SM, Mukherjee P, Vigneron DB, Nelson SJ. PMID: 18096412; PMCID: PMC2377156.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    85. Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma. AJNR Am J Neuroradiol. 2007 Sep; 28(8):1455-61. Lupo JM, Cha S, Chang SM, Nelson SJ. PMID: 17846190; PMCID: PMC2855720.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    86. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol. 2007 Jun-Jul; 28(6):1078-84. Cha S, Lupo JM, Chen MH, Lamborn KR, McDermott MW, Berger MS, Nelson SJ, Dillon WP. PMID: 17569962; PMCID: PMC8134129.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    87. Feasibility of dynamic susceptibility contrast perfusion MR imaging at 3T using a standard quadrature head coil and eight-channel phased-array coil with and without SENSE reconstruction. J Magn Reson Imaging. 2006 Sep; 24(3):520-9. Lupo JM, Lee MC, Han ET, Cha S, Chang SM, Berger MS, Nelson SJ. PMID: 16888776.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    88. Partially-parallel, susceptibility-weighted MR imaging of brain vasculature at 7 Tesla using sensitivity encoding and an autocalibrating parallel technique. Conf Proc IEEE Eng Med Biol Soc. 2006; 2006:747-50. Lupo JM, Banerjee S, Kelley D, Xu D, Vigneron DB, Majumdar S, Nelson SJ. PMID: 17945996.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    89. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol. 2005 Jun-Jul; 26(6):1446-54. Lupo JM, Cha S, Chang SM, Nelson SJ. PMID: 15956514; PMCID: PMC8149056.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    Janine's Networks
    Concepts (201)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (85)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.